Androstenones

Abstract

The present invention relates to methods for preparing and using compounds of formula (I), wherein carbons 1 and 2 are joined by either a single or a double bond; R1 is hydrogen or methyl; R2 is hydrogen or methyl; R3 is (A) wherein X, W, Z, R4, and R5, are various groups, and pharmaceutically acceptable solvates thereof and their use in the treatment of androgen responsive and mediated diseases.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 2, 1999
  • Application: May 14, 1998
    US US 7900298 A
  • Priority: May 14, 1998
    US US 7900298 A
  • Priority: Oct 12, 1993
    US US 13651593 A
  • Priority: Sep 17, 1993
    US US 12328093 A

Download Citation


Sign in to the Lens

Feedback